coronavirus

Quote






























anonymous said:
I'm guessing NEOS
Click to expand...

If it's Neos Therapeutics that would be fantastic. Their stock has a 5 year high of $27.00 and is currently trading for $1.22!! I'm sure they have viable products with a robust pipeline. NOT!!!!

Go waste $50M somewhere else Supernus. This has the Biscayne acquisition written all over it (how can we get the best stock pop by spending the least amount of money).
 






anonymous said:
If it's Neos Therapeutics that would be fantastic. Their stock has a 5 year high of $27.00 and is currently trading for $1.22!! I'm sure they have viable products with a robust pipeline. NOT!!!!

Go waste $50M somewhere else Supernus. This has the Biscayne acquisition written all over it (how can we get the best stock pop by spending the least amount of money).
Click to expand...


Correction their stock is currently trading at $0.91!!! Stop shopping at the flea market Supernus!!
 






Hey everyone, just had a great experience I wanted to share.

with everyone on lockdown due to Wuhan virus concerns, I decided to use my passion for Peloton to engage with my accounts.

since I became a Peloton trainer, I decided to set up a Team Trokendi training ride three times a day. My doctors and staff love it! They are getting fit while we discuss the merits of Trokendi over CGRPs and it has cut back on my travel and lunch budgets.

this is a great way to save the company money while building lasting relationships and increasing fitness.

remember, you didn’t wake up to be mediocre!
Go Team Trokendi!
 


















anonymous said:
I'm guessing NEOS
Click to expand...

Let me spell something out for Supernus management who obviously reads all the crap on this site. DO NOT BUY ANYTHING WITH REFORMULATION. EVERYONE WILL QUIT. WE HAVE TO MOVE FORWARD AS A COMPANY. INSURANCE COMPANY’S DONT COVER THESE PRODUCTS ANYMORE AND WE ARE DOING A DISSERVICE TO 95% OF OUR PATIENTS WHO WONT BENEFIT FROM LESS DROWSINESS OR QD DOSING.
 






anonymous said:
Let me spell something out for Supernus management who obviously reads all the crap on this site. DO NOT BUY ANYTHING WITH REFORMULATION. EVERYONE WILL QUIT. WE HAVE TO MOVE FORWARD AS A COMPANY. INSURANCE COMPANY’S DONT COVER THESE PRODUCTS ANYMORE AND WE ARE DOING A DISSERVICE TO 95% OF OUR PATIENTS WHO WONT BENEFIT FROM LESS DROWSINESS OR QD DOSING.
Click to expand...

Let me spell something out for you. I DON’T CARE WHAT I SELL. I ONLY CARE THAT MY PAYCHECK KEEPS GETTING DEPOSITED. IF WE BUY A UNIQUE PRODUCT WE BECOME MORE VALUABLE FOR ACQUISITION. WHAP HAPPENED TO SHIRE WHEN THEY BOUGHT PRODUCTS WHICH WEREN’T REFORMULATED? THEY WERE BOUGHT. I DON’T WANT TO BE BOUGHT. WE ALSO NEED TO STOP WORRYING SO MUCH ABOUT THE STOCK PRICE. FEW OF US HAVE ANY STOCK. WE WILL MAKE OUR LIVING OFF OF OUR SALARY AND AVERAGE BONUS. AS LONG AS ANY PURCHASE KEEPS US WITH JOBS UNTIL I GET CLOSER TO NOT WORKING, I DON’T CARE
 


















anonymous said:
Let me spell something out for Supernus management who obviously reads all the crap on this site. DO NOT BUY ANYTHING WITH REFORMULATION. EVERYONE WILL QUIT. WE HAVE TO MOVE FORWARD AS A COMPANY. INSURANCE COMPANY’S DONT COVER THESE PRODUCTS ANYMORE AND WE ARE DOING A DISSERVICE TO 95% OF OUR PATIENTS WHO WONT BENEFIT FROM LESS DROWSINESS OR QD DOSING.
Click to expand...

What do you think our business model is? A smart company doesn’t extend itself beyond its core competencies. Our core competency is reformulation not new chemical entities. It’s done well for us so far with this year(1 of 7 as a commercial organization) as an exception. $1B doesn’t buy you a lot in pharma world, but it does buy you reformulations that are low cost development and high return (even if you are fighting for coverage.)

These are the facts. Either use Supernus as a stepping stone or come to terms with what we are and make the best of it.
 






anonymous said:
Let me spell something out for you. I DON’T CARE WHAT I SELL. I ONLY CARE THAT MY PAYCHECK KEEPS GETTING DEPOSITED. IF WE BUY A UNIQUE PRODUCT WE BECOME MORE VALUABLE FOR ACQUISITION. WHAP HAPPENED TO SHIRE WHEN THEY BOUGHT PRODUCTS WHICH WEREN’T REFORMULATED? THEY WERE BOUGHT. I DON’T WANT TO BE BOUGHT. WE ALSO NEED TO STOP WORRYING SO MUCH ABOUT THE STOCK PRICE. FEW OF US HAVE ANY STOCK. WE WILL MAKE OUR LIVING OFF OF OUR SALARY AND AVERAGE BONUS. AS LONG AS ANY PURCHASE KEEPS US WITH JOBS UNTIL I GET CLOSER TO NOT WORKING, I DON’T CARE
Click to expand...

This makes no sense! That’s great you don’t care about what you sell but buying another reformulated product won’t give you long term pay checks or bonuses i.e look at our diminishing sales currently. Also the idea we should only sell turds the rest of our lives just so we don’t get bought out is ridiculous. Shire was bought when there golden goose was running dry. They bought those turd xr drugs to keeps the ship a float. It’s precisely why I think Supernus should not buy another xr drug. We need to get out this xr business so we can actually have long sustained growth and revenue.
 






anonymous said:
What do you think our business model is? A smart company doesn’t extend itself beyond its core competencies. Our core competency is reformulation not new chemical entities. It’s done well for us so far with this year(1 of 7 as a commercial organization) as an exception. $1B doesn’t buy you a lot in pharma world, but it does buy you reformulations that are low cost development and high return (even if you are fighting for coverage.)

These are the facts. Either use Supernus as a stepping stone or come to terms with what we are and make the best of it.
Click to expand...

I understand the business model but it should be a means to an end instead of kicking the can down the road. Before you get too proud of yourself with GROSS FACTORY SALES why dont you look at net sales. We gave away a tremendous amount of product with GC to make Supernus look amazing and the only reason we got those scripts was due to GC. Drs weren’t sold any differently on the product. And as you can see now It’s back to reality. Xr drugs only get you so far in today’s market. I’m saying this cause I like the company but it’s time to innovate or buy innovation. I agree 1 bill cash doesn’t do this so don’t spend it on crap!!!
 






anonymous said:
What do you think our business model is? A smart company doesn’t extend itself beyond its core competencies. Our core competency is reformulation not new chemical entities. It’s done well for us so far with this year(1 of 7 as a commercial organization) as an exception. $1B doesn’t buy you a lot in pharma world, but it does buy you reformulations that are low cost development and high return (even if you are fighting for coverage.)

These are the facts. Either use Supernus as a stepping stone or come to terms with what we are and make the best of it.
Click to expand...

You need to be escorted out of Rockville.
 






anonymous said:
I understand the business model but it should be a means to an end instead of kicking the can down the road. Before you get too proud of yourself with GROSS FACTORY SALES why dont you look at net sales. We gave away a tremendous amount of product with GC to make Supernus look amazing and the only reason we got those scripts was due to GC. Drs weren’t sold any differently on the product. And as you can see now It’s back to reality. Xr drugs only get you so far in today’s market. I’m saying this cause I like the company but it’s time to innovate or buy innovation. I agree 1 bill cash doesn’t do this so don’t spend it on crap!!!
Click to expand...

So it sounds like we kinda agree so maybe this is a lesson on communication? That post is probably the most sense you’ve ever made but Is still laced with anger and accusation. It doesn’t matter how smart loyal or high performing you are; if you talk to people like that you will be dismissed as a dumb disgruntled and underperforming rep. Not saying this to be holier than thou, just truly trying to help you get your point across better.
 












Top Bottom
Back
Quote